Synthesis and biological evaluation of spin-labeled alkylphospholipid analogs

Journal of Medicinal Chemistry

Volumn 48, Issue 20, 2005, Pages 6393-6399

  Mravljak, Janez ^a   Zeisig, Reiner ^b   Pečar, Slavko ^a,c  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

4 [[[[13 (2 BUTYL 3 OXYL 4,4 DIMETHYL 1,3 OXAZOLIDINE 2 YL)TRIDECYL]OXY](OXY)PHOSPHORYL]OXY] 1,1 DIMETHYLPIPERIDINIUM; ALKYL GROUP; ANTINEOPLASTIC AGENT; LIPOSOME; MILTEFOSINE; PERIFOSINE; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL STRAIN MCF 7; CHEMICAL STRUCTURE; DRUG CYTOTOXICITY; DRUG TARGETING; ELECTRON SPIN RESONANCE; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; MICELLE; SYNTHESIS;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYCLIC N-OXIDES; DRUG SCREENING ASSAYS, ANTITUMOR; HEMOLYSIS; HUMANS; LIPOSOMES; MICELLES; PHOSPHOLIPIDS; PHOSPHORIC ACID ESTERS; PHOSPHORYLCHOLINE; SOLUTIONS; SPIN LABELS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE-ACTIVE AGENTS;

EID: 26444566761     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050189v     Document Type: Article

References (45)

1. (a) Houlihan, W. J.; Lohmeyer, M.; Workman, P.; Cheon, S. H. Phospholipid Antitumor Agents. Med. Res. Rev. 1995, 15, 157-223.
2. (b) Brachwitz, H.; Vollgraf, C. Analogs of Alkyllysophospholipids: Chemistry, Effects on the Molecular Level and Their Consequences for Normal and Malignant Cells. Pharmacol. Ther. 1995, 66, 39-82.
3. (c) Principe, P.; Braquet, P. Advances in ether phospholipids treatment of cancer. Crit. Rev. Oncol. Hematol. 1995, 78, 155-178.
4. 3), ilmofosine (BM 41.440) and the hexadecylphosphocholines D-20133 and D-21266 on histamine release from isolated rat mast cells. Immunopharmacology 1999, 44, 211-221.
5. (a) Unger, C.; Eibel, H.; Breiser, A.; Von Heyden, H. W.; Engel, J.; Hilgard, P.; Sindermann, H.; Peukert, M.; Nagel, G. A. Hexadecylphosphocholine (D-18506) in the topical treatment of skin metastases - a phase-I trial. Onkologie. 1988, 11, 295-296.
6. (b) Unger, C.; Herrmann, R.; Berdel, W. E.; Kleeberg, U. R.; Gatzemeier, U.; Illiger, H. J.; Wander, H. E.; Westerhausen, M.; Becher, R.; Bremer, K.; Rieche, K.; Essers, U.; Queisser, W.; Heidemann, E.; Fiebif, H. H.; Possinger, K.; Jourdainmandl, B.; Heim, M. E.; Edler, L. Topically applied miltefosine (hexadecylphosphocholine) in patients with skin-metastasized breast-cancer - a phase II study. Onkologie 1993, 16, 170-173.
7. Unger, C.; Peukert, M.; Sindermann, H.; Hilgard, P.; Nagel, G.; Eibl, H. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Prog. Exp. Tumor Res. 1992, 34, 153-159.
8. Zeisig, R.; Arndt, D.; Stahn, R.; Fichtner, I. Physical properties and pharmacological activity in vitro and in vivo of optimised liposomes prepared from a new cancerostatic alkylphospholipid. BBA-Biomembranes 1998, 1414, 238-248.
9. (a) Hilgard, P.; Klenner, T.; Stekar, J.; Nossner, G.; Kutscher, B.; Engel, J. D-21266, a new heterocyclic alkylphospholipid with antitumour activity. Eur. J. Cancer. 1997, 33, 442-446.
10. (b) Engel, J.; Hilgard, P.; Klenner, T.; Kutscher, B.; Nossner, G.; Traiser, M.; Voss, V. Perifosine-Oncolytic-Ether phospholipid. Drugs Future 2000, 25, 1257-1260.
11. Grunicke, H. H.; Maly, K.; Uberall, F.; Schubert, C.; Kindler, E.; Stekar, J.; Brachwitz, H. Cellular signaling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction. Adv. Enzyme Regul. 1996, 36, 385-407.
12. (a) Mollinedo, F.; Gajate, C.; Martin-Santamaria, S.; Gago, F. ET-18-OCH3 (Edelfosine): A selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor. Curr. Med. Chem. 2004, 11, 3163-3184.
13. (b) Ogretmen, B.; Hannun, Y. A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 2004, 4, 604-616.
14. (c) Wieder, T.; Orfans, C. E.; Geilen, C. C. Induction of Ceramide-mediated Apoptosis by the Anticancer Phospholipid Analog, Hexadecylphosphocholine. J. Biol. Chem. 1998, 273, 11025-11031.
15. 2-Ceramide and Its Relationship to Apoptosis. Mol. Pharmacol. 2002, 62, 1068-1075.
16. (e) Jiménez-López, J. M.; Carrasco, M. P.; Segovia J. L.; Marco, C. Hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis and the proliferation of HepG2 cells. Eur. J. Biochem. 2002, 269, 4649-4655.
17. (f) Rahmani, M.; Reese, E.; Dai, Y.; Bauer, C.; Payne, S. G.; Dent, P.; Spiegel, S.; Grant, S. Coadministration of Histone Deacetylase Inhibitors and Perifosine Synergistically Induces Apoptosis in Human Leukemia Cells through Akt and ERK1/2 Inactivation and the Generation of Ceramide and Reactive Oxygen Species. Cancer Res. 2005, 65, 2422-2431.
18. (g) Ruiter, G. A.; Zerp, S. F.; Bartelnik, H.; Blitterswijk, W. J.; Verheij, M. Alkyl-Lysophospholipids Activate the SAPK/JNK Pathway and Enhance Radiation-induced Apoptosis. Cancer Res. 1999, 59, 2457-2463.
19. (a) Joseph, J.; Shih, C. C. Y.; Lai, C. S. Synthesis of the spin-labeled derivative of an ether-linked phospholipid possessing high antineoplastic activity. Chem. Phys. Lipids 1991, 58, 19-26.
20. (b) Sosnovsky, G.; Lukszo, J.; Brasch, R. C. Preparation of an Aminoxyl Analog of the Anticancer Agent Miltefosine. Z. Naturforsch. B 1996, 51, 888-890.
21. (a) Griffith, O. H.; Jost, P. C. Lipid Spin Labeles in Biological Membranes. In Spin Labeling I, Theory and Applications; Berliner, L. J., Ed.; Academic Press Inc.: New York, 1976; pp 453-523.
22. (b) McConnell, H. M. Molecular Motion in Biological Membranes. In Spin Labeling I, Theory and Applications; Berliner, L. J., Ed.; Academic Press Inc.: New York, 1976; pp 525-560.
23. (c) Strancar, J.; KokliC, T.; Arsov, Z. Soft Picture of Latheral Heterogeneity in Biomembranes. J. Membr. Biol. 2003, 196, 135-146.
24. (a) Smith, I. C. P.; Butler, K. W. Oriented Lipid Systems as Model Membranes. In Spin Labeling I, Theory and Applications; Berliner, L. J., Ed.; Academic Press Inc.: New York, 1976; pp 411-451.
25. (b) Marsh, D.; Páli, T.; Horváth, L. I. Progressive Saturation and Saturation Transfer EPR for Measuring Exchange Processes and Proximity Relations in Membranes. In Spin Labeling, The Next Millenium, Biological Magnetic Resonance; Berliner, L. J., Ed.; Plenum Press: New York, 1998; Vol. 14, pp 23-82.
26. (a) Hubbell, W. L.; McConnell, H. M. Molecular Motion in Spin-Labeled Phospholipids and Membranes. J. Am. Chem. Soc. 1971, 93, 314.
27. (b) Hubbell, W. L.; McConnell, H. M. Orientation and motion of amphiphilic spin labels in membranes. Proc. Nat. Acad. Sci. U.S.A. 1969, 64, 20.
28. (c) Keana, J. F. W. Synthesis and Chemistry of Nitroxide Spin Labels. In Spin Labeling in Pharmacology; Holtzman, J. L., Ed.; Academic Press: New York, 1984; pp 1-85.
29. (d) Gaffney, B. J. The Chemistry of Spin Labels. In Spin Labeling I, Theory and Applications; Berliner, L. J., Ed.; Academic Press Inc.: New York, 1976; pp 184-238.
30. (a) Keana, J. F. W.; Bernard, E. M.; Roman, R. B. Selective Reduction of Doxyl and Proxyl Nitroxide Carboxylic Acids to the Corresponding Alcohols with Borane Methyl Sulfide. Synth. Commun. 1978, 8, 169-173.
31. (b) Sanson, A.; Ptak, M.; Rigaud, J. L.; Gary-Bobo, C. M. An ESR study of the anchoring of spin-labeled stearic acid in lecithin multilayers. Chem. Phys. Lipids 1976, 17, 435-444.
32. Becker, H. G. O.; Berger, W.; Domschke, G.; Fanghänel, E.; Faust, J.; Fischer, M.; Gentz, F.; Gewald, K.; Gluch, R.; Mayer, R.; Müller, K.; Pavel, D.; Schmidt, H.; Schollberg, K.; Schwetlick, K.; Seiler, E.; Zeppenfeld, G. Reduction von Carbonylverbindungen durch Aluminium- und Borhydride. In Organikum; Wiley-VCH Verlag GmbH: Weinheim, 2001; pp 568-572.
33. Noessner, G.; Kutscher, B.; Engel, J.; Schumacher, W.; Stekar, J.; Hilgard, P. Novi alkilni ali alkenski fosfati, postopek za njihovo pripravo in njihova uporaba kot zdravilnega sredstva. SI Patent 9 300 365 A, 1993.
34. (a) Chandrakumar, N. S.; Hajdu, J. Stereospecific Synthesis of Ether Phospholipids. Preparation of 1-Alkyl-2-(acylamino)-2- deoxyglycerophosphorylcholines. J. Org. Chem. 1983, 48, 1197-1202.
35. (b) Bhatia, S. K.; Hajdu, J. Stereospecific Synthesis of Ether and Thioether Phospholipids. The Use of L-Glyceric Acid as a Chiral Phospholipid Precursor. J. Org. Chem. 1988, 53, 5034-5039.
36. (c) Menger, F. M.; Chen, X. Y.; Brocchini, S.; Hopkins, H. P.; Hamilton, D. Synthesis and Thermotropic Properties of Macrocyclic Lipids Related to Archebacterial Membranes. J. Am. Chem. Soc. 1993, 115, 6600-6608.
37. Rakotomanga, M.; Loiseau, P. M.; Saint-Pierre-Chazalet, M. Hexadecylphosphocholine interaction with lipid monolayers. Biochim. Biophys. Acta. 2004, 1661, 212-218.
38. (a) Bratton, D. L.; Harris, R. A.; Clay, K. L.; Henson, P. M. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. Biochim. Biophys. Acta. 1988, 941, 76-82.
39. (b) Noseda, A.; Godwin, P. L.; Modest, E. J. Effects of antineoplastic ether lipids on model and biological membranes. Biochim. Biophys. Acta. 1988, 945, 92-100.
40. (a) Fleer, E. A. M.; Berkovic, D.; Unger, C.; Eibl, H. Cellular uptake and metabolic-fate of hexadecylphosphocholine. Prog. Exp. Tumor Res. 1992, 34, 33-46.
41. (b) Kötting, J.; Marschner, N. W.; Neumüller, W.; Unger, C.; Eibl, H. Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine - a comparison of hemolytic-activity, serum binding and tissue distribution. Prog. Exp. Tumor Res. 1992, 34, 131-142.
42. (a) Kocherginsky, N.; Swartz, H. M. Chemical Reactivity of Nitroxides. In Nitroxide Spin Labels; Kocherginsky, N., Swartz, H. M., Eds.; CRC Press: Boca Raton, FL, 1995; pp 27-66.
43. (b) Swartz, H. M.; Sentjurc, M.; Kocherginsky, N. Metabolism of Nitroxides and Their Products in Cells. In Nitroxide Spin Labels; Kocherginsky, N., Swartz, H. M., Eds.; CRC Press: Boca Raton, FL, 1995; pp 27-66.
44. (c) Prelesnik, T.; Nemec, M.; Pečar, S.; Demšar, F.; Kveder, M.; Schara, M. Oxygen in free radical reactions. Vestn. Slov. Kem. Drus. 1986, 33, 153-155.
45. Stensrud, G.; Passi, S.; Larsen, T.; Sandset, P. M.; Smistad, G.; Mönkkönen, J.; Karlsen, J. Toxicity of gamma irradiated liposomes. 1. In vitro interactions with blood components. Int. J. Pharm. 1999, 178, 33-46.